NO Image

8th Annual Congress on Cell Science, Stem Cell Research and Regenerative Medicine

Jun 06-07, 2024

|

Chicago, United States of America





Cell Science, Stem Cell Research and Regenerative Medicine



Welcome message  

LexisConferences cordially invites you to participate in the 8th Annual Congress on Cell Sciences and Regenerative Medicine, Stem Cell 2024, scheduled to take place on June 6-7, 2024, in the vibrant city of Chicago, USA.

Stem Cell 2024 serves as a premier platform for experts, researchers, students, and scientists to converge and share their ideas and insights on the fascinating realm of Stem Cells. Through engaging oral talks and presentations, participants will delve into the latest advancements, research findings, and innovations, contributing to a profound understanding of this cutting-edge field.

About Conference

LexisConferences is organizing the 8th Annual Congress on Cell Sciences, Stem Cells, and Regenerative Medicine Conference will provide a common platform to leaders in research, industrial experts, and trainees so that we can share the new ideas and facts  in the respective fields leading to the development of new generation stem cell technologies. The objective of the conference is to make people aware of stem cells and their related diseases and treatment. Stem cell embryology can be used to regenerate or repair diseased tissue or organs.

In the realm of stem cell transplants, these remarkable cells play a pivotal role in either replacing diseased or chemotherapy-damaged cells or collaborating with the donor's immune system to combat specific cancers and blood-related ailments such as leukemia, lymphoma, neuroblastoma, and multiple myeloma.

Furthermore, inadequately healed spinal cord injuries may lead to progressive nerve damage. Notably, in an experiment, nearly 45% of patients who underwent stem cell therapy experienced outstanding outcomes. The potential for groundbreaking medical therapies is substantial with the promising capabilities of stem cells.

Researchers can leverage certain types of stem cells to conduct preliminary tests on new medications, assessing their quality and safety before progressing to human trials. This innovative approach is expected to significantly impact the development of drugs, particularly in areas such as cardiac toxicity testing.

Speakers, delegates, scholars, researchers, and keynote speakers will mark their presence at the conference. We respect your valuable time and appreciate your till date contribution to the area of Cell Science.

 

Brochure

 

 

 

Why attend?

Stem Cell 2024 Conference will provide an ideal platform to express the views and knowledge in deep about the latest research work done in the stem cell field. Debate to reduce the gaps and priorities which will lead to the development of next-generation stem cell technologies to measure the future aspects and updates related to the stem cells. The event will provide an opportunity to interact with well-known speakers and industry experts.

Target audience

Keynote Speakers | Renowned Speakers | Eminent Personalities | Association Heads | Directors | CEO | Organization Or Institution Heads | Stem Cell Laboratory Heads & Researchers | Post-Docs | Students Along With Companies Can Be Targeted As The Audience

Abstract Submission Details
The organizing committee of the Stem Cell 2024 Conference would like to invite speakers to submit their research for inclusion in the Stem Cells 2024 scientific program. 

Submit your abstract online at Speaker abstract (or)  Email to: stemcellscongress@meetingsnexpo.com

Market analysis-

Market analysis for the Stem Cell and regenerative medicine industry typically encompasses factors such as technological advancements, research breakthroughs, regulatory landscape, and market trends. This sector has witnessed significant growth in recent years due to increasing investments, expanding applications in treating various diseases, and a growing focus on personalized medicine.

The scheduled conference in Chicago is likely to serve as a pivotal platform for industry leaders, researchers, and stakeholders to discuss the latest developments and innovations. Attendees can expect insightful presentations from key opinion leaders, discussions on cutting-edge research, and opportunities for networking and collaboration.

To gain a comprehensive understanding of the market dynamics and trends, participants should engage with speakers, exhibitors, and fellow attendees. This conference is anticipated to contribute valuable insights into the future direction of stem cell and regenerative medicine, fostering partnerships and accelerating advancements in this rapidly evolving field. Stay tuned for updates on market analysis, emerging technologies, and strategic initiatives within the stem cell and regenerative medicine sector during the conference in June 2024.

Stem Cell Market

The growing number of clinical trials being conducted globally is helping the stem cell market expand. The majority of stem cell therapy trials are being conducted in North America, primarily the United States. With approximately 77.4% of the whole North American market, the United States dominates the industry in both the product and banking services areas.

But Asia-Pacific is expanding at the fastest rate. In regenerative medicine, stem cells play a significant role, particularly in dermatology. Oncology, however, is anticipated to experience the fastest growth rate due to the abundance of pipeline drugs available for the treatment of tumours or cancers. The number of regenerative medicine facilities is predicted to grow along with the stem cell market.

Market researchers anticipate that from 2017 to 2022, the global market for stem cell therapy will expand at a CAGR of 36.52%.

With the backing of government initiatives, stem cell banking is becoming more significant. In emerging nations, there are more stem cell banks than ever before, which is helping the market expand. Additionally, the market has benefited from individuals being more aware of stem cell storage. The United States contributed the highest share to the region's overall stem cell market, which was dominated by North America. The Sanford Clinical Center for Stem Cells at the University of A clinical experiment to evaluate the safety of neural stem cell-based therapy in patients with persistent spinal cord damage has been announced by the California, San Diego (UCSD) Health System. The implanted stem cells were expected to differentiate into new neurons that would take the place of severed or damaged nerve connections and perhaps restore at least some motor and sensory functions. The growth of the stem cell market has been aided by the vast number of stem cell studies conducted across the US to evaluate the safety of neural stem cell-based therapy in patients with persistent spinal cord damage has been announced by the California, San Diego (UCSD) Health System. The implanted stem cells were expected to differentiate into new neurons that would take the place of severed or damaged nerve connections and perhaps restore at least some motor and sensory functions. The growth of the stem cell market has been aided by the vast number of stem cell studies conducted across the US.

There are many significant participants in the fiercely competitive stem cell business. Few of the big competitors now control the majority of the market in terms of market share. Major market players like Thermo Fisher Scientific, Qiagen NV, Sigma Aldrich (A Subsidiary of Merck KGaA), Becton, Dickinson and Company, and Stem Cell Technologies are present, which is resulting in an increase in the level of market competition. The key players' improvements to stem cell technology and product developments are escalating their competitive competition.

America's and the world's societies are significantly impacted by cancer. In 2018, the National Cancer Institute predicted that 1,735,350 new instances of cancer will be diagnosed in the country, and 609,640 people would pass away from the disease. The population is growing, which is causing this rising medical burden. Some diseases, including leukaemia, multiple myeloma, neuroblastoma, and some forms of lymphomas, can be treated by a bone marrow or stem cell transplant. Due to their greater totipotency and longer longevity than adult stem cells, which have a shorter lifespan and lower totipotency, embryonic stem cells (ESC) are the primary source of stem cells for therapeutic uses. However, the application of ESCs to research and medical

The market is expanding positively, but because stem cell-based research is receiving more attention and could increase clinical applications, stem cell therapy may be prohibitively expensive, still impede its development.

It provides in-depth information and enhances market variations for the global stem cell therapy market to assist you in settling on the winning plan. It includes comprehensive data on the most recent advancements, manufacturing trends, industry structural changes, and shifting market dynamics. The market for stem cell therapy will expand at a CAGR of 36.52% from 2017 to 2021. While the European stem cell market is anticipated to expand at a CAGR of 9.45% between 2018 and 2026. The market is developing primarily as a result of rising R&D expenditures in adult stem cell research in the area, ease of administration, and the rising prevalence of chronic diseases as a result of demographic shifts in lifestyle. The UK, France, Germany, Spain, Italy, and the rest of Europe are the nations that made up the analysis of the European stem cell market. The majority of these nations have stable economies, allowing their citizens to spend more on healthcare. Based on technology, product, and applications, the Europe stem cell market has been divided into segments in this study.

Stem Cells 2023 Report 
LexisConferences Conferences hosted the event “7th Annual congress on Cell sciences, Stem Cells and Regenerative Medicine to be held from March 17-18, 2023” .The conferences were organized with a focus on the themes Diving Into Stem Cell Novel Approaches was a great success where eminent keynote speakers from various reputed companies and Universities made their resplendent presence and addressed the gathering.

The event proceedings were carried out through several Scientific-sessions and plenary lectures, LexisConferences would like to express a sincere thankfulness to all the Honourable guests and Keynote Speakers of 7th Annual congress on Cell sciences, Stem Cells and Regenerative Medicine. We would like to convey a warm gratitude to all the Honourable guests and Keynote Speakers of Stem Cells 2023.

Stem Cells 2023 committee would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers Alejandro De La Parra-Solomon from World Academy of Medical Sciences, Mexico; Ahmed G Hegazi from Academy of Scientific Research & Technology, Egypt; Alireza Heidari from Cancer Research Institute, USA; Jenny Wang from Harvard Medical School, Australia; CP Abdolrasoul Aleezaadeh from Brooklyn Central University, New York; Kazi Ahsan Jamil from National University of Singapore, Japan have given a wonderful talk which makes allows the delegates and other attendees to gain the knowledge about main course of the event.

Stem Cells 2023 Organizing Committee would like to thank the Moderator of the conference, Alireza Heidari from Cancer Research Institute, USA, who contributed a lot for the smooth functioning of this event and for taking up the responsibility to coordinate during the sessions for smooth functioning of this event. We are indebted to your support.

LexisConferences conferences also took the privilege of felicitating Stem Cells 2023 Organizing Committee, Keynote Speakers, Plenary Speakers, Chairs and Co-Chairs, Young Researchers and other attendees whose support made the conference a great success.

We also would like to thank all our Speakers, Poster Presenters and Delegates for taking out your time and sharing their research work with our peer network. We are very glad to have shared a great relationship with all these Attendees, associations and we hope to see even greater support in our upcoming events. We would also like to thank Chairs and Co-chairs of the conference, Alireza Heidari from Cancer Research Institute, USA; Jenny Wang from Harvard Medical School, Australia; CP Abdolrasoul Aleezaadeh from Brooklyn Central University, New York; Kazi Ahsan Jamil from National University of Singapore, Japan for a being a great support for our event to be a grand success. A series of lectures by distinguished professionals discussed the recent trends and issues in inter-disciplinary Rheumatology and its technical advancements.

With a great response and feedback which we received from participants and supporters from Stem Cells 2023, we are proud to announce our upcoming conferences in the Series 8th Annual Congress on Cell Science, Stem Cell Research and Regenerative Medicine on June 6-7 , 2024 in Chicago, United States Of America with the theme of Promising a New Path for Stem Cells and Regenerative Medicines.

The main aim of this conference is to solicit the gracious presence of our honourable, to the upcoming conference “8th Annual Congress on Cell Science, Stem Cell Research and Regenerative Medicine ” that is going to be held during June 6-7, 2024 in Chicago, United States Of America to share and exchange their knowledge. It is an International platform for business delegates, B2B meetings, poster presentations, workshops, symposia, networking and more. It will offer a platform wherein you can ensure enormous exposure and networking by exhibiting products and services. Grab the opportunities, and share your innovative ideas, new technologies and recent researches.

Stem Cells 2024 witnesses an amalgamation of peerless speakers who enlightened the gathering with their contribution towards the prevention of Stem Cell related difficulties, its effects and treatment on Oncology.

For being a Experts in Stem Cells and Regenerative Medicine, we hope that this platform gives knowledge and new updates by undergoing with the several interactive sessions to encourage the exchange of innovative ideas in the field of Stem Cells and its advancements, in that all the session talks are consider to be a great talks which makes the delegates, exhibitor, collaborators and other speakers feels so much interesting.

Being a significant expert in this area we would like to Invite you as an International Organizing Committee Members, Speakers, Keynote speakers, Young Research forum, Sponsors and Exhibitor, etc for Stem Cells 2024.Our goal is to deliver an outstanding program which covers the entire spectrum of research & innovations in Oncology, Stem Cell and share the cross-cultural experiences of various principles and practices.

The centre of the activity of Stem Cells 2024 is to produce the clear visual definition by undergoing with Oral Presentation, Poster presentation, Workshop, Exhibition, networking and interacting session. With the feedback from your renowned Speakers, we have added some of the new Session Tracks that need to be focused such as such as Stem Cells| Regenerative Medicine| Computational Biology| Immunology| Tumor Cell Science| Novel Stem Cells| Drugs and Clinical Development| Stem Cell Embryology.

With the great support we have successfully completed Stem Cells 2023 and we are expecting huge response and support from the Stem Cell and Regenerative Medicine, Doctors, Oncology Professionals, Young researchers, Students, Delegates, Directors and other Stem Cell and Regenerative Medicine related companies to have your gracious presence at Stem Cells 2024 on June 6-7 , 2024 in Chicago, USA to make this congress a great successful event of the year 2024.

Join our team Stem Cells 2024 at this beautiful city of USA and let’s make this professional gathering a Great success

Contact us:

Eva Wilson| Program Manager

Email us : stemcellscongress@meetingsnexpo.com
 

Stem cells banking values from 2012-2023 Stem cells help develop oncology disorder segments and in research areas leading to the development of new therapies like regenerative therapies use of induced pluripotent stem cells. These stem cells are used as an alternative to embryonic stem cells so that they can contribute high revenue.

The main advantage in market development is the high totipotency and indefinite lifespan of stem cells. The top companies competing in the market for stem cell products are Thermo Fischer Scientific, Qiagen NV, Sigma competing in the market for stem cell products are Thermo Fischer Scientific, Qiagen NV, Sigma Aldrich, Becton, Dickinson and company, and stem cell technologies.

Societies Of USA

American Society for Cell Biology (ASCB).

ASGCT - American Society of Gene & Cell Therapy.

American Society for Biochemistry and Molecular Biology.

 

Societies Of UK

British Society for Gene and Cell Therapy.

UK Society for Cell Culture Biotechnology.

International Society for Stem Cell Research.

Stem cells and human health | Royal Society.

 

Societies Of France

French Society for Stem Cell Research

Stem Cells and Technoscience: Sociology of the Emergence

Frontiers in Cancer Research and Therapy

 

Societies Of Japan

The Japanese Society for Regenerative Medicine

Japan's Stance on Stem Cell Research

The Japan Society of Transfusion Medicine and Cell Therapy

Lucy
Renee A Reijo Pera
University of Wisconsin

Biography

Renee Reijo Pera is a stem cell biologist and the President of the McLaughlin Research Institute in Great Falls, MT. She previously served as Vice President of Research and Economic Development, for more than 8 years at the California Polytechnic State University and at Montana State University.

Researches :

  • Stem Cell Biology & Regenerative Medicine
Lucy
Gregory E Lutz
Cornell University

Biography

Dr. Gregory E. Lutz is Physiatrist-In-Chief Emeritus at HSS and a Professor of Clinical Rehabilitation Medicine at Weill Medical College of Cornell University. In addition, he is the Founder and Medical Director of Regenerative SportsCare Institute (RSI) in Manhattan.

Researches :

  • Physiatry, Spine
Lucy
Mrs Kelli Mauric
Owner Entreprenuer at Balance the Brain Professional Corp

Lucy
Dr CP Abdolrasoul Aleezaadeh
Brooklyn Central UniversityGreen Lake University

Lucy
Dr Jenny Wang
Harvard Medical SchoolChildrens Cancer Institute

Lucy
Dr Alireza Heidari
Cancer Research InstituteAmerican International Standards Institute

Lucy
Dr Ahmed G Hegazi
Academy of Scientific Research Technology

Lucy
Alejandro De La Parra-Solomon

Lucy
Ali Shakeri-Zadeh
Assistant Professor
Department of Radiology and the Cellular Imaging Section
Johns Hopkins

Biography

Dr. Shakeri-Zadeh is an Assistant Professor in the Department of Radiology. His research is focused on developing multifunctional nanostructures for theranostic purposes. He has pioneered the development of folate-conjugated magneto-plasmonic nanoparticles for cancer imaging and therapy. Using multifunctional nanoplatforms he has applied different imaging modalities for treatment planning of nanoparticle-assisted cancer therapy.

Researches :

  • Nanomedicine; Theranostic Nanoparticles; Cell Labeling; In vivo Cell Tracking; Multimodal Image?Guided Photothermal/Radiation Cancer Therapy
Lucy
Mrs Kelli Mauric
Owner Entreprenuer at Balance the Brain Professional Corp

Lucy
Dr Pradeep Mahajan
StemRx Bioscience Solutions Pvt Ltd

Lucy
Kazi Ahsan Jamil
National University of Singapore

Program Overview

Our Collaborations, Sponsors, Media Partners